|
EIF3A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54760000004028E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.08729999998203E-06 |
| Normal-vs-Stage2 |
2.373700E-04 |
| Normal-vs-Stage3 |
9.236400E-03 |
| Normal-vs-Stage4 |
1.235600E-01 |
| Stage1-vs-Stage2 |
7.469800E-01 |
| Stage1-vs-Stage3 |
7.014200E-01 |
| Stage1-vs-Stage4 |
8.836200E-01 |
| Stage2-vs-Stage3 |
5.253200E-01 |
| Stage2-vs-Stage4 |
7.033400E-01 |
| Stage3-vs-Stage4 |
9.256600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.19379999996561E-06 |
| Normal-vs-AfricanAmerican |
6.833200E-04 |
| Normal-vs-Asian |
2.998100E-03 |
| Caucasian-vs-AfricanAmerican |
6.934200E-01 |
| Caucasian-vs-Asian |
6.085800E-01 |
| AfricanAmerican-vs-Asian |
5.122800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.77069999668578E-08 |
| Normal-vs-Female |
1.361010E-01 |
| Male-vs-Female |
4.964300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.256900E-03 |
| Normal-vs-Extreme_Weight |
1.15939999822956E-08 |
| Normal-vs-Obese |
2.881700E-03 |
| Normal-vs-Extreme_Obese |
1.400340E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.524600E-01 |
| Normal_Weight-vs-Obese |
4.394600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.963800E-01 |
| Extreme_Weight-vs-Obese |
9.301200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.227000E-01 |
| Obese-vs-Extreme_Obese |
2.139000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.643800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.550900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.46219999996866E-07 |
| Normal-vs-Age(81-100Yrs) |
1.743780E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.813200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.366300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.408300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.721900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.099800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.032800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.92349999986286E-07 |
| Normal-VS-Type2 PRCC |
4.566600E-04 |
| Normal-VS-KIRP CIMP |
8.645400E-01 |
| Normal-VS-Unclassified PRCC |
6.088200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.002600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.129900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.457360E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.354430E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.250400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.545000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.22270000077773E-08 |
| Normal-vs-N1 |
2.650800E-01 |
| Normal-vs-N2 |
1.087570E-01 |
| N0-vs-N1 |
6.584100E-03 |
| N0-vs-N2 |
4.024400E-01 |
| N1-vs-N2 |
6.487400E-01 |
|
|
